Validation for clinical utility of biomarkers for the early diagnosis of breast cancer
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0005212
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 496
Inclusion Criteria
Breast Cancer patients
- Women over 18
- Patients diagnosed with breast cancer by biopsy before treatment (patients before surgery and neoadjuvant chemotherapy)
Exclusion Criteria
- Carcinoma in situ
- Recurrent breast cancer patient
- Any person diagnosed with another cancer within five years.
- Patients who started treatment after being diagnosed with breast cancer
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prospective demonstrate the diagnostic validity of blood based biomarkers for early diagnosis of breast cancer
- Secondary Outcome Measures
Name Time Method Comparison of changes in blood-based biomarkers before and after breast cancer treatment -To determine if there is any usefulness to follow up